Cornell researchers have developed a new vaccine platform that could provide more robust, longer-lasting protection from both ...

The new vaccine addresses significant limitations of existing COVID-19 and flu vaccines. While mRNA COVID-19 vaccines require ...

Early data suggest that the 2024-2025 flu shots have effectively lowered rates of flu hospitalization and outpatient visits ...

Two long-planned vaccine meetings — one at the US Centers for Disease Control and another at the US Food and Drug ...

In February 2025, flu rates spiked to the highest levels seen in at least 15 years, with flu outpacing COVID-19 infections ...

Is it possible to get the flu twice in the same season? Experts share who is more likely to get reinfected and how to stay ...

After speculation as to whether this year’s flu vaccine could be poorly matched to the current strain of flu, new Centers for ...

The analysis estimates that annual global seasonal flu vaccine production capacity has remained relatively stable since 2019, ...

Flu vaccination campaigns such as the CDC’s Wild to Mild are designed to translate science into easily understood messages ...

H5N2 is a different subtype than the H5N1 subtype ... of the conditional use license and early successes with bird flu vaccines in other countries. Still, he noted that there is still a lot ...

Soaring egg prices have consumers boiling, and on Wednesday, the United States Department of Agriculture blamed rising costs ...

Cornell University researchers have developed a new vaccine platform that could provide more robust, longer-lasting protection from both COVID-19 and influenza, and broader immunity to different flu ...